Verrica Pharmaceuticals Inc. (VRCA) Financials

VRCA Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 97.1 million 54.8 million
2023-06-30 62.2 million 6.8 million
2023-03-31 68.6 million 3.8 million
2022-12-31 44.7 million 4.7 million

VRCA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -14.9 million 9.7 million
2023-06-30 -4.7 million 1.5 million
2023-03-31 -4.6 million 1.1 million
2022-12-31 -5.0 million 1.2 million

VRCA Net Income

No data available :(

VRCA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 84.3 million - 1.4 million
2023-06-30 55.1 million - 1.4 million
2023-03-31 60.0 million - 1.5 million
2022-12-31 34.3 million - 1.5 million

VRCA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 46.1 million
2023-06-30 45.9 million
2023-03-31 43.0 million
2022-12-31 41.1 million

VRCA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 65000 6.5 million 20.1 million -
2023-06-30 59000 5.7 million 5.9 million -
2023-03-31 11000 2.7 million 4.3 million -
2022-12-31 66000 3.0 million 3.2 million -

VRCA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 2.9 million 145000
2023-06-30 182000 136000
2023-03-31 37000 68000
2022-12-31 68000 62000

VRCA

Price: $6.76

52 week price:
2.86
7.76

Earnings Per Share: -1.48 USD

P/E Ratio: -5.10

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 337100

Market Capitalization: 299.1 million

Links: